| Mark A. Perrotti,m.d.llc | |
|
251 W Main St Branford CT 06405-4047 | |
| (203) 481-0077 | |
| Not Available |
| Full Name | Mark A. Perrotti,m.d.llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 251 W Main St, Branford, Connecticut |
| Authorized Official Name and Position | Mark Anthony Perrotti (PRESIDENT) |
| Authorized Official Contact | 2034810077 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mark A. Perrotti,m.d.llc 251 W Main St Branford CT 06405-4047 Ph: (203) 481-0077 | Mark A. Perrotti,m.d.llc 251 W Main St Branford CT 06405-4047 Ph: (203) 481-0077 |
| NPI Number | 1982637823 |
|---|---|
| Provider Enumeration Date | 07/07/2006 |
| Last Update Date | 08/22/2020 |
| Medicare PECOS PAC ID | 1456364579 |
|---|---|
| Medicare Enrollment ID | O20060713000046 |
News Archive
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.
A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).
Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982637823 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 037644 (Connecticut) | Primary |
| Provider Name | Mark A Perrotti |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1699723049 PECOS PAC ID: 5991718082 Enrollment ID: I20060712000178 |
News Archive
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.
A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).
Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.
› Verified 4 days ago
| Provider Name | Amy Smith |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750617817 PECOS PAC ID: 5698946556 Enrollment ID: I20110926000487 |
News Archive
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.
A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).
Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.
› Verified 4 days ago
| Provider Name | Alyssa Anderson |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1336421171 PECOS PAC ID: 9436303518 Enrollment ID: I20130128000160 |
News Archive
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.
A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).
Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.
› Verified 4 days ago
| Provider Name | Roseanna Petonito |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1679128102 PECOS PAC ID: 2668703786 Enrollment ID: I20191003002542 |
News Archive
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.
A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).
Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.
› Verified 4 days ago
| Provider Name | Alexa Canavan |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669134045 PECOS PAC ID: 9739579822 Enrollment ID: I20211203001314 |
News Archive
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.
A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).
Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.
› Verified 4 days ago
News Archive
INNOPHARMA LLC announced today FDA approval of the Abbreviated New Drug Application (ANDA) for ibutilide fumarate injection (the generic equivalent of Corvert® from Pfizer Inc).
Focused ultrasound can effectively destroy tumor cells. Until now, this method has only been used for organs such as the prostate and uterus.
A startling new case study of Chicago, led by a team of researchers at Northwestern University in Illinois, USA, suggests a 16-fold higher incidence of SARS-CoV-2 infection than previously thought. This is judging from seroprevalence (antibody presence blood testing) figures, rather than the number of RT-PCR-positives reported there (via swab sample testing of symptomatic patients).
Worldwide, good progress has been made towards some of the health-related Sustainable Development Goals (SDGs) since 2000, particularly in reducing under-5 and neonatal mortality, family planning, and the rollout of universal health care.
› Verified 4 days ago
Center For Orthopaedics Division Of Connecticut Orthopaedic Specialist Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1224 Main St, Branford, CT 06405 Phone: 203-752-3100 Fax: 203-752-9291 | |
Fair Haven Community Health Clinic Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 221 W Main St, Branford, CT 06405 Phone: 203-777-7411 Fax: 203-777-8506 | |
Livella Care, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4 Brushy Plain Rd, Suite 519, Branford, CT 06405 Phone: 203-214-4527 | |
Branford Internal Medicine Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 500 E Main St, Suite 212, Branford, CT 06405 Phone: 203-481-5665 Fax: 203-481-5524 | |
J.t. Bristol, M.d., Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 84 N Main St, Branford, CT 06405 Phone: 203-483-2015 Fax: 203-483-2016 | |
Digestive Disease Associates, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1224 Main St, Branford, CT 06405 Phone: 203-481-0315 Fax: 203-481-6788 | |
American Natural Health Care And Medicine, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 365 E Main St, Suite 4, Branford, CT 06405 Phone: 203-589-9349 Fax: 888-729-5733 |